Global health or global wealth?

Journal name:
Nature Biotechnology
Volume:
28,
Pages:
907–909
Year published:
DOI:
doi:10.1038/nbt0910-907

As health biotech enterprises in emerging economies move from imitation to innovation, will they become less relevant to local global health priorities?

References

  1. Daar, A.S. et al. Nature 450, 494496 (2007).
  2. Gustavsen, K. & Hanson, C. Health Aff. 28, 17451749 (2009).
  3. Towse, A. & Kettler, H. Bull. World Health Organ. 83, 301307 (2005).
  4. Grabowski, H. Health Aff. 24, 697700 (2005).
  5. Ridley, D.B., Grabowski, H.G. & Moe, J.L. Health Aff. 25, 313324 (2006).
  6. Dentzer, S. Health Aff. 28, w411w416 (2009).
  7. Lister, S. GlaxoSmithKline to share malaria research in hope of finding a cure. Times Online (2010). <http://www.timesonline.co.uk/tol/news/science/medicine/article6994620.ece>
  8. Frew, S. E. et al. Nat. Biotechnol. 26, 3753 (2008).
  9. Frew, S.E. et al. Nat. Biotechnol. 25, 403417 (2007).
  10. Rezaie, R., Frew, S.E. & Sammut, S.M. Nat. Biotechnol. 26, 627644 (2008).
  11. Al-Bader, S., Frew, S.E. & Essajee, I. Nat. Biotechnol. 27, 427445 (2009).
  12. <http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/OrphanDrugAct/default.htm> (2009; accessed 10 January 2010).
  13. Frew, S.E., Kettler, H.E. & Singer, P.A. Health Aff. 27, 10291041 (2008).
  14. Frew, S., Liu, V. & Singer, P. Health Aff. 28, 17601773 (2009).

Download references

Author information

Affiliations

  1. Rahim Rezaie and Peter A. Singer are at the McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Competing financial interests

P.A.S. has received consulting funds from Merck Frosst Canada and is on the scientific advisory board of the BioVeda II fund in China.

Corresponding author

Correspondence to:

Author details

Additional data